PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D)- ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GL ...
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72112-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)72112-X/fulltext
Title :
PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D)- ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GL ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72112-X&doi=10.1016/S1098-3015(11)72112-X
First page :
A293
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
271